Events

Safety Alert for Merlin@home Transmitter

According to National Authority of Drugs and Health Products (Infarmed, Portugal), this safety alert involved a device in Portugal that was produced by St. Jude Medical.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Date
    2017-09-08
  • Event Country
    Portugal
  • Event Source
    NADHPIP
  • Event Source URL
    http://www.infarmed.pt/web/infarmed/alertas/-/journal_content/56/15786/2259477
  • Notes / Alerts
    Portuguese data is current through October 2018. All of the data comes from the National Authority of Drugs and Health Products (Infarmed, Portugal), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Portugal.
  • Extra notes in the data
  • Action
    Merlinhome Transmitter - Cybersecurity Updates

Device

Merlin@home Transmitter

Manufacturer

St. Jude Medical
  • Manufacturer Parent Company (2017)
    Abbott Laboratories
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    NADHPIP